Patents Assigned to Origent Data Sciences, Inc.
-
Patent number: 12633383Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.Type: GrantFiled: June 4, 2024Date of Patent: May 19, 2026Assignee: Origent Data Sciences, Inc.Inventors: David L. Ennist, Albert A. Taylor, Danielle E. Beaulieu, Michael A. Keymer
-
Publication number: 20250069710Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.Type: ApplicationFiled: June 4, 2024Publication date: February 27, 2025Applicant: Origent Data Sciences, Inc.Inventors: David L. ENNIST, Albert A. TAYLOR, Danielle E. BEAULIEU, Michael A. KEYMER
-
Patent number: 12002553Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.Type: GrantFiled: October 4, 2021Date of Patent: June 4, 2024Assignee: Origent Data Sciences, Inc.Inventors: David L. Ennist, Albert A. Taylor, Danielle E. Beaulieu, Michael A. Keymer
-
Publication number: 20220139505Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.Type: ApplicationFiled: October 4, 2021Publication date: May 5, 2022Applicant: Origent Data Sciences, Inc.Inventors: David L. ENNIST, Albert A. TAYLOR, Danielle E. BEAULIEU, Michael A. KEYMER
-
Patent number: 11139051Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.Type: GrantFiled: October 2, 2018Date of Patent: October 5, 2021Assignee: Origent Data Sciences, Inc.Inventors: David L. Ennist, Albert A. Taylor, Danielle E. Beaulieu, Michael A. Keymer
-
Publication number: 20200105380Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.Type: ApplicationFiled: October 2, 2018Publication date: April 2, 2020Applicant: Origent Data Sciences, Inc.Inventors: David L. ENNIST, Albert A. TAYLOR, Danielle E. BEAULIEU, Michael A. KEYMER